摘要
Objectives: We aimed to examine whether metformin (MET) use is associated with a reduced risk of total knee arthroplasty (TKA) and low severity of knee pain in patients with knee osteoarthritis (OA) and diabetes and/or obesity. Methods: Participants diagnosed with knee OA and diabetes and/or obesity from June 2000 to July 2019 were selected from the information system of a local hospital. Regular MET users were defined as those with recorded prescriptions of MET or self-reported regular MET use for at least 6 months. TKA information was extracted from patients' surgical records. Knee pain was assessed using the numeric rating scale. Log-binomial regression, linear regression, and propensity score weighting (PSW) were performed for statistical analyses. Results: A total of 862 participants were included in the analyses. After excluding missing data, there were 346 MET non-users and 362 MET users. MET use was significantly associated with a reduced risk of TKA (prevalence ratio: 0.26, 95% CI: 0.15 to 0.45, p < 0.001), after adjustment for age, gender, body mass index, various analgesics, and insurance status. MET use was significantly associated with a reduced degree of knee pain after being adjusted for the above covariates (beta: -0.48, 95% CI: -0.91 to -0.05, p = 0.029). There was a significantly accumulative effect of MET use on the reduced risk of TKA. Conclusion: MET can be a potential therapeutic option for OA. Further clinical trials are needed to determine if MET can reduce the risk of TKA and the severity of knee pain in metabolic-associated OA patients.
学科与关键词
- Metformin use and associated risk of total joint replacement in patients with type 2 diabetes: a population-based matched cohort studyZhu, Zhaohua; Huang, Jing-Yang; Ruan, Guangfeng; Cao, Peihua; Chen, Shibo; Zhang, Yan; Han, Weiyu; Chen, Tianyu; Cai, Xiaoyan; Liu, Jia; Tang, Yujin; Yu, Na; Wang, Qian; Hunter, David J.; Wei, James Cheng-Chung; Ding, Changhai*Canadian Medical Association journal, 2022, 194(49): E1672-E1681.被引 1
- Metformin Reduces the Risk of Total Hip Arthroplasty in Elderly Patients with Hip Osteoarthritis and Type 2 Diabetes MellitusLi, Fuchun*DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16: 3481-3487.
- Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trialRuan, Guangfeng; Yuan, Shiwen; Lou, Aiju; Mo, Yingqian; Qu, Yuan; Guo, Dongmei; Guan, Shangqi; Zhang, Yan; Lan, Xiaoyong; Luo, Jun; Mei, Yifang; Zhang, Hongwei; Wu, Weirong; Dai, Lie; Yu, Qinghong; Cai, Xiaoyan*; Ding, Changhai*BMC MUSCULOSKELETAL DISORDERS, 2022, 23(1): 486.被引 4
